Seminars in Radiation Oncology
Volume 16, Issue 2 , Pages 102-110, April 2006

Molecular Correlates of Site-Specific Metastasis

  • Charlotte Y. Dai, MD, PhD

      Affiliations

    • Department of Radiation Oncology, UCSF Comprehensive Cancer Center, San Francisco, CA
  • ,
  • Christopher M. Haqq, MD, PhD

      Affiliations

    • Department of Urology and Prostate Cancer Program, UCSF Comprehensive Cancer Center, San Francisco, CA
    • Corresponding Author InformationAddress reprint requests to Charlotte Dai, MD, PhD, Department of Radiation Oncology, UCSF Comprehensive Cancer Center, San Francisco, CA 94143
  • ,
  • J. Edward Puzas, MD

      Affiliations

    • Department of Orthopaedics, University of Rochester School of Medicine and Dentistry, Rochester, NY

Metastasis is the spread of tumor cells from a primary site to distant organs. It is the major cause of cancer morbidity and death. In the last few decades, significant advances have been made in surgical techniques, radiation therapy delivery, and chemotherapy including the development of combination regimens and agents inhibiting newly characterized biological targets. Treatment of metastasis, however, remains the most challenging task in cancer therapy because metastatic growth relies on complex interactions between tumor cells and the host and is often resistant to all therapeutic modalities. Management of metastasis in bone is especially challenging given the difficulty of access for therapeutic agents. Contemporary research seeks to explain the striking organ specificity observed in metastasis. In this article, we will examine historic perspectives on site-specific metastasis and review cellular and molecular evidence pertinent to the mechanisms of organ specificity. We will discuss a number of studies that aim to identify gene signatures correlating with organ-selective metastasis using microarray technology. Lastly, we will discuss potential areas of future research including microRNAs, proteomics, and the development of diagnostic and therapeutic interventions.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S1053-4296(05)00100-1

doi:10.1016/j.semradonc.2005.12.005

Seminars in Radiation Oncology
Volume 16, Issue 2 , Pages 102-110, April 2006